|
TIME
|
PROGRAM DETAIL
|
||
|---|---|---|---|
|
08:45-09:30
|
Keynote Speaker Session II
On a journey with coronavirus replication organelles: how far have we come? Helena Maier, The Pirbright Institute (GB) |
||
|
09:30 - 11:05
|
Scientific Session 3.1 Topic: Immune Response to Virus Infection
Chairs: Stanley Perlman, University of Iowa (US) Susan Weiss, University of Pennsylvania (US) |
||
|
09:30 - 09:55
|
Invited speaker talk
Coronavirus activation of interferon signaling pathways is critical for control of infection in the nasal epithelium Susan Weiss, University of Pennsylvania (US) |
||
|
09:55-10:10
|
Investigating the role of Toll-like receptor 7 in SARS-CoV-2 infection using golden hamsters
Ziyi Guo, The University of Tokyo (JP) |
||
|
10:10-10:25
|
SARS-CoV-2 Balances Antigenic Evolution and Replicative Fitness in Human Airways
Anna Mykytyn, Erasmus MC (NL) |
||
|
10:25-10:35
|
Chronic Infection Drives Evolution of SARS-CoV-2 Innate Immune Antagonism
Xiaohao Xu, King's College London (GB) |
||
|
10:35-10:45
|
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity
Arinjay Banerjee, University of Saskatchewan (CA) |
||
|
10:45-10:55
|
Infection-induced immune imprinting following SARS-CoV-2 exposure in unvaccinated populations
Adam Abdullahi, University of Cambridge (GB) |
||
|
10:56-11:05
|
Flash Talks and Discussions
Cross-species quantification of antiviral immune responses from large-scale RNA-seq data using ISG Profiler Luca Nishimura, The University of Tokyo (JP) Cellular innate immune determinants of SARS-CoV-2 clearance and disease severity Margarida Bonifacio, The Francis Crick Institute (GB) |
||
|
11:05 - 11:25
|
Break
|
||
|
11:25 - 12:40
|
Scientific Session 3.2 Topic: Virus Transmission and Vaccines
Chairs: Yunlong Cao, Peking University (CN) Stanley Perlman, University of Iowa (US) |
||
|
11:25-11:50
|
Invited speaker talk
Airborne transmission of SARS-CoV-2 Kanta Subbarao, Université Laval (CA) |
||
|
11:50-12:05
|
Population-wide SARS-CoV-2 antibody repertoire heterogeneity driven by immune imprinting
Yunlong Cao, Peking University (CN) |
||
|
12:05-12:20
|
Breadth and kinetics of antibody-mediated immunity to SARS-CoV-2 variants in highly-vaccinated individuals receiving monovalent KP.2 mRNA COVID-19 booster vaccines
Daniel Egan, University of Cambridge (GB) |
||
|
12:20-12:35
|
SARS-CoV-2 Variants Employ Diverse Strategies to Sustain Efficient Airborne Transmissibility
Jie Zhou, Imperial College London (GB) |
||
|
12:36-12:40
|
Flash talk and Discussions
COVID-19 vaccination induces cross-neutralisation of sarbecoviruses related to SARS-CoV Grace West, University of Cambridge (GB) |
||
|
12:40-13:00
|
Global Perspectives on Epidemic and Pandemic Preparedness II
CEPI CoV Library Georges Thiry/ José Slon Campos, CEPI (Coalition for Epidemic Preparedness Innovations) |
||
|
13:00-14:00
|
Lunch
|
||
|
14:00-15:35
|
Scientific Session 3.3 Topic: Vaccinesn
Chairs: Yunlong Cao, Peking University (CN) Bart Haagmans, Erasmus MC (NL) Chee Wah Tan, National University of Singapore (SG) |
||
|
14:00-14:25
|
Invited speaker talk
Attenuation of PEDV Virulence by an NSP3 Mac1 Mutation with Unchanged In Vitro Replication Qiuhong Wang, The Ohio State University (US) |
||
|
14:25-14:40
|
Mouse V(D)J Humanization Recapitulates human-like Severe SARS-CoV-2 Immune Imprinting
Xiao Niu, Peking University (CN) |
||
|
14:40-14:55
|
mRNA-based COVID-19 JN.1 Vaccination Induces Partial Protection Against SARS-CoV
Merel te Marvelde, Erasmus Medical Center (NL) |
||
|
14:55-15:05
|
Application of Organoid-Derived Human Bronchiole Cultures for Manufacture of Human Coronaviruses Used in Controlled Human Infection Models
Jingshu Zhang, Erasmus MC (NL) |
||
|
15:05-15:15
|
Broad Sarbecovirus Neutralization Elicited by a Synthetic SARS-CoV-2-Based Variant Immunogen Cocktail
Viren Baharani, The Rockefeller University (US) |
||
|
15:15-15:35
|
Break
|
||
|
15:35-16:25
|
Global Perspectives on Epidemic and Pandemic Preparedness III
Introduction to The Hong Kong Jockey Club Global Health Institute Frank Konings, The Hong Kong Jockey Club Global Health Institute Lessons from SARS CoV 2 intrahost evolution in immune suppression Ravindra Gupta, University of Cambridge (GB) |
||
|
16:25-18:00
|
Poster Session II
|
||
|
18:00 - 21:00
|
Conference Dinner
|
||
